“…The diastereoismer with (R) configuration at C-4 of substituted octahydro-2Hchromen-4-ol exhibits biological activity, while the S-diastereomer practically does not show any effect. [49] Besides homogenous Lewis catalysts such as I 2 (81 %, R/S = 5 : 1), [50] BF 3 • OEt 2 (60 %, R/S = 3 : 1), [51] Prins reaction between isopulegol and carbonyl compounds was also perfomed over heterogenous Lewis catalysts such as acid-activated montmorillonite (75.7 %, R/S = 5.3 : 1), [52,53] sulfonic acid modified K10 clay (73 %, R/S = 7.6 : 1) [49] or organosilylated sulfur containing K10 clay (90 %, R/S = 11.5 : 1), [54] acid-modified illite L-1 clay (81.7 %, R/S = 6.8 : 1), [55] halloysite nanotubes (77 %, R/S = 8.4 : 1), [56,57] acid-modified halloysite nanotubes (97 %, R/S = 6.6 : 1), [58] beta zeolites (93.3 %, R/S = 6.6 : 1), [59] Ce-MCM-41 (100 %, R/S mixture), [60] mesoporous Ce-composite (96 %, R/S mixture), [61] HCl-kaolin (90 %, R/S = 6.2 : 1) and HCl-metakaolin solids (86 %, R/S = 6.8 : 1) (Figure 1). [62,63] The first application of the octahydro-2H-chrome core, prepared in one step via the reaction of (À )-isopulegol 2 with different 2-thiophenecarboxaldehyde derivatives, against influenza A virus was reported by Nizamova et al in 2017.…”